Plain-English translation of NCT01851694 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Cystic fibrosis can damage the pancreas and affect how the body controls blood sugar, leading to cystic fibrosis-related diabetes. This study is testing whether two hormones called and can help pancreatic cells release more insulin in people with this condition. Researchers will give participants the medication through an IV and measure how much insulin their body makes in response.
Scientists recently discovered that cystic fibrosis-related diabetes may work differently than previously thought—it may be similar to type 2 diabetes in some ways. This treatment appears to help people with type 2 diabetes, but no one knows yet whether it will help people with cystic fibrosis-related diabetes improve their insulin levels.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for study visits where you'll have tests to measure how your pancreas responds to blood sugar changes. During some visits, researchers will give you one of the two hormones through an IV for about 90 minutes while they test your insulin levels. At other visits, you'll receive a placebo (salt solution) so researchers can compare your body's response. You'll also complete some standard glucose tolerance tests, and the research team won't know which treatment you're getting until all the results are collected.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States